A randomised controlled trial comparing the efficacy of withdrawing alpha blocker following initial combination therapy with dual 5 alpha reductase inhibitor (5-ARI) dutasteride compared to continuation of combination therapy in the management of benign prostatic hyperlasia /
Saved in:
Main Author: | Krishna Kumar |
---|---|
Format: | Thesis Book |
Language: | English |
Published: |
Kuala Lumpur :
Universiti Kebangsaan Malaysia,
2012.
|
Subjects: | |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparing the effectiveness of tocotrienol rich fraction and alpha tocoferol with combination of vitamin C in the management of systemic inflammatory response syndrome (SIRS) /
by: Elmehrik, Husam Yousef
Published: (2013) -
Combination therapy for optimum glycaemic control : a randomized open label trial comparing rosiglitazone with combination sulphonylureas and metformin tablets in type 2 diabetes mellitus
by: Ghazali, Wan Syamimee Wan
Published: (2006) -
Combination of metformin and FEC (5-Fluorouracil, Epirubicin, Cyclophophasmide) chemotherapy as a potential therapy for targeting cancer stem cells in breast cancer /
by: Sian, Soo Siu
Published: (2015) -
The effect of voiding position on uroflowmetry findings of patients with Benign Prostatic Hyperlasia (BPH) in urology clinic, Hospital Tengku Ampuan Afzan (HTAA), Kuantan, Pahang /
by: Muhd Zaki Azre bin Redzuan
Published: (2016) -
Development and biochemical characterisation of novel blockers of 5-hydroxytrptamine receptors /
by: Li, Haixin
Published: (2001)